Skip to Content

News: November, 2022

‘Multi-omics’ reveals treatment option for breast cancer subtype

Friday, November 18th, 2022

In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy.